TITLE

A sub-population of high proliferative potential-quiescent human mesenchymal stem cells is under the reversible control of interferon α/β

AUTHOR(S)
Peiffer1, I; Eid2, P; Barbet3, R; Li4, M L; Oostendorp5, R A J; Haydont6, V; Monier7, M-N; Milon8, L; Fortunel9, N; Charbord10, P; Tovey11, M; Hatzfeld12, J; Hatzfeld13, A
PUB. DATE
August 2007
SOURCE
Leukemia (08876924);Aug2007, Vol. 21 Issue 8, p1848
SOURCE TYPE
Academic Journal
DOC. TYPE
Correction notice
ABSTRACT
A correction to the article "A sub-population of high proliferative potential-quiescent human mesenchymal stem cells is under the reversible control of interferon α/β" in the previously published issue is presented.
ACCESSION #
25791511

 

Related Articles

  • Stem Cells: The next cure? Dyer, Nicole // Science World;11/12/2001, Vol. 58 Issue 5, p14 

    Highlights the therapeutic use of stem cells. INSETS: How Stem Cells Grow Body Parts;Is Stem-Cell Research Ethical?.

  • Easy stem cell production published in Nature "does not work". Hawkes, Nigel // BMJ: British Medical Journal;5/17/2014, Vol. 348 Issue 7958, p5 

    The article reports that scientist Kenneth Lee and colleagues disproved a claim published in the journal "Nature" by a team from Japan's RIKEN Centre for Developmental Biology that immersing mouse stem cells in a bath of warm acid restored them to a pluripotent state.

  • Of mice, men and stem cells: developments in cellular therapy. Biela, Chris // Journal of Renal Nursing;Mar2014, Vol. 6 Issue 2, p95 

    No abstract available.

  • Creating 'Spare Parts' for the Human Body.  // USA Today Magazine;Jun1998 Science, Vol. 126 Issue 2637, p4 

    Reports on a study of neural stem cells conducted by professor of surgery, Mary Pat Moyer.

  • Corrigendum to “Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells”. Rahmani, Anahita; Kheradmand, Danial; Keyhanvar, Peyman; Shoae-Hassani, Alireza; Darbandi-Azar, Amir // BioMed Research International;2/16/2015, Vol. 2015, p1 

    No abstract available.

  • Clinical grade stem cells are created by scientists at King's College London. Hawkes, Nigel // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;12/10/2011, Vol. 343 Issue 7835, p1178 

    The article reports that the scientists at King's College London developed clinical grade stem cells which are free of products derived from animals. It states that the products, called xeno-free stem cells, are submitted to the Great Britain Stem Cell Bank. Meanwhile, professor Peter Braude...

  • Corrigendum: Therapeutic targeting of a stem cell niche. Adams, Gregor B; Martin, Roderick P; Alley, Ian R; Chabner, Karissa T; Cohen, Kenneth S; Calvi, Laura M; Kronenberg, Henry M; Scadden, David T // Nature Biotechnology;Aug2007, Vol. 25 Issue 8, p944 

    This article presents a correction of the January 2007 issue regarding a paper on targeting stem cell niches.

  • Stem cell-ness: a "magic marker" for cancer. Lahad, John P.; Mills, Gordon B.; Coombes, Kevin R. // Journal of Clinical Investigation;Aug2005, Vol. 115 Issue 8, p2298 

    Presents a correction to the article "Stem Cell-Ness: A "Magic Marker" for Cancer," by John P. Lahad, Gordon B. Mills and Kevin R. Coombes, published in the 2005 issue of the "Journal of Clinical Investigation."

  • Erratum.  // Journal of Clinical Investigation;Mar2011, Vol. 121 Issue 3, p1222 

    A correction to the article "Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity" that was published in the 2011 issue is presented.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics